OC
OCGN icon

Oppenheimer & Co’s Ocugen OCGN Stock Holding History

Oppenheimer & Co’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,805
Closed -$79.3K – 1816
2026
Q1 		$79.3K Hold
43,805
– – ﹤0.01% 1653
2025
Q4 		$59.1K Hold
43,805
– – ﹤0.01% 1508
2025
Q3 		$71.4K Hold
43,805
– – ﹤0.01% 1617
2025
Q2 		$42.5K Buy
43,805
+7,650
+21% +$6.34K ﹤0.01% 1587
2025
Q1 		$25.5K Hold
36,155
– – ﹤0.01% 1553
2024
Q4 		$29.1K Hold
36,155
– – ﹤0.01% 1535
2024
Q3 		$35.9K Hold
36,155
– – ﹤0.01% 1487
2024
Q2 		$56K Buy
+36,155
New +$56.3K ﹤0.01% 1402

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Oppenheimer & Co's OCGN Position: Q2 2026 in Review

Oppenheimer & Co sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 43,805 shares — an estimated $79.3K sold.

Oppenheimer & Co first reported a position in OCGN in Q2 2024 and held it in 8 quarters. The position peaked at $79.3K in Q1 2026. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Oppenheimer & Co reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
  • Oppenheimer & Co sold 43,805 Ocugen shares in Q2 2026, an estimated $79.3K.
  • Oppenheimer & Co first reported a position in Ocugen in Q2 2024 and held it in 8 quarters.
  • Oppenheimer & Co's Ocugen position peaked at $79.3K in Q1 2026.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.